LONDON --(BUSINESS WIRE)--Mar. 22, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2023 results on Wednesday, May 3, 2023 at 1 p.m.   London time ( 8 a.m. Eastern Time ).

LONDON --(BUSINESS WIRE)--Mar. 9, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lung Machine (HLM).

LONDON --(BUSINESS WIRE)--Mar. 9, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald , Chief Executive Officer, will present in a fireside chat at the Barclays Global Healthcare Conference in Miami, Florida .

LONDON --(BUSINESS WIRE)--Feb. 22, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023. Fourth-Quarter Financial Summary and Highlights 1

LONDON --(BUSINESS WIRE)--Feb. 8, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*. The release has been initiated in select centers throughout Europe ,

New device expands access to the latest technology for legacy VNS Therapy patients with drug-resistant epilepsy in the U.S. LONDON --(BUSINESS WIRE)--Feb. 2, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today launched SenTiva DUO™, an implantable

LONDON --(BUSINESS WIRE)--Jan. 18, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m.   London time ( 8 a.m. Eastern Time ).